Dermatology · Coral Gables, FL
NPI
1700839057
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6705 Red Road, Ste 400
Coral Gables, FL, 33143
Phone (305) 668-8201
Groups this clinician bills Medicare through
Medicare paid, 2024
$394K
5,469 services
Medicare patients, 2024
560
Average age 76
Drug cost, 2024
$762K
3,151 prescriptions
Company payments, 2025
$2,644
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Javier Flores was code 17003 (destruction skin lesion), 2,425 times for 372 patients. In total Javier Flores billed 5,469 services in 79 codes, and Medicare paid $394K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,425 | 372 | $5.27 | $13K |
| 17000 Destruction Skin Lesion | Office | 627 | 394 | $39.96 | $25K |
| 99213 Office E&M - Established | Office | 525 | 336 | $69.15 | $36K |
| 99212 Office E&M - Established | Office | 330 | 233 | $42.16 | $14K |
| 11102 Skin Biopsy | Office | 312 | 251 | $68.12 | $21K |
| 17110 Destruction Skin Lesion | Office | 210 | 175 | $82.47 | $17K |
| 17004 Destruction Skin Lesion | Office | 84 | 66 | $133.09 | $11K |
| 99203 Office E&M - New | Office | 81 | 81 | $85.70 | $6,942 |
| 17311 Mohs Surgery | Office | 78 | 67 | $460.39 | $36K |
| 11103 Skin Biopsy | Office | 62 | 55 | $41.70 | $2,585 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 50 | 11 | $0.72 | $36.18 |
| 17312 Mohs Surgery | Office | 47 | 38 | $361.85 | $17K |
| 13121 Wound Repair - All Levels | Office | 43 | 38 | $237.46 | $10K |
| 99202 Office E&M - New | Office | 28 | 28 | $27.36 | $766 |
| 17313 Mohs Surgery | Office | 26 | 25 | $521.12 | $14K |
By year: 2022 $288K for 4,766 services; 2023 $337K for 5,519 services; 2024 $394K for 5,469 services.
Medicare prescription drug claims, 2024
In 2024, the drug Javier Flores prescribed most often to Medicare patients was Ketoconazole, with 513 prescriptions and refills. In total Javier Flores wrote 3,151 Medicare prescriptions that cost $762K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 513 | 554 | 204 | $7,349 |
| Triamcinolone Acetonide Generic | 478 | 528 | 278 | $5,219 |
| Hydrocortisone Generic | 267 | 280 | 139 | $3,579 |
| Betamethasone Dipropionate Generic | 224 | 238 | 124 | $8,587 |
| Ammonium Lactate Generic | 212 | 224 | 76 | $4,901 |
| Mupirocin Generic | 184 | 185 | 109 | $1,434 |
| Ciclopirox Generic | 141 | 161 | 55 | $4,829 |
| Mometasone Furoate Generic | 121 | 136 | 69 | $2,815 |
| Clobetasol Propionate Generic | 104 | 119 | 41 | $6,816 |
| Metronidazole Generic | 103 | 109 | 56 | $4,554 |
| Fluorouracil Generic | 71 | 72 | 53 | $6,018 |
| Erythromycin Erythromycin Base In Ethanol | 66 | 71 | 40 | $1,413 |
| Imiquimod Generic | 58 | 65 | 28 | $2,860 |
| Doxycycline Hyclate Generic | 49 | 49 | 21 | $725 |
| Fluocinolone Acetonide Generic | 45 | 49 | 28 | $2,325 |
Brand drugs: 153 claims; generic drugs: 2,998 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Javier Flores $2,644 ($2,644 in general payments such as food, travel and fees) from 18 companies. The largest payer was Janssen Biotech, Inc. with $758.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 27 | $758 |
| LEO Pharma Inc. | 8 | $368 |
| Abbvie Inc. ABBV | 8 | $343 |
| Arcutis Biotherapeutics, Inc. ARQT | 16 | $181 |
| Incyte Corporation INCY | 9 | $168 |
| Pfizer Inc. PFE | 8 | $161 |
| Lilly USA, LLC LLY | 5 | $151 |
| Amgen Inc. AMGN | 2 | $126 |
| Galderma Laboratories, L.P. GALD.SW | 3 | $71.04 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $68.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.